Lonza Group AG against Teva Pharmaceutical Industries Limited — live side-by-side technical comparison.
Prices as of 2026-10-09T15:30:13+00:00 UTC · updates daily
TEVA leads 5 of the 5 windows we measure — over 1 month LONN.SW is +6.4% and TEVA +11.5%; over year to date LONN.SW is +6.4% and TEVA +31.7%.
| LONN.SW | TEVA | |
|---|---|---|
| Price | $572.20 | $41.10 |
| 1 day | +1.6% | +4.7%lead |
| 5 days | +1.2% | +4.0%lead |
| 1 month | +6.4% | +11.5%lead |
| 6 months | +13.0% | +32.8%lead |
| Year to date | +6.4% | +31.7%lead |
| 52-week position | 82% of range | 96% of range |
| 52-week range | $454.60–$597.80 | $18.83–$42.02 |
| vs 50-day average | above $567.17 | above $37.62 |
| vs 200-day average | above $532.37 | above $33.91 |
| RSI (14) | 61 | 57 |
| Next earnings | 2026-01-28 | 2026-11-03 |
LONN.SW trades at $572.20, above its 50-day average of $567.17, and above the 200-day at $532.37. It sits at 82% of its 52-week range ($454.60–$597.80); 14-day RSI is 61, in neutral territory; an average session moves it about 2.4%. For levels, the first level overhead is $580.40 (1.4% away) and the first support below is $567.17 (0.9% down). On the checklist the page runs for every asset, 6 of 6 checks read bullish — the lean is bullish.
TEVA trades at $41.10, above its 50-day average of $37.62, and above the 200-day at $33.91. It sits at 96% of its 52-week range ($18.83–$42.02); 14-day RSI is 57, in neutral territory; an average session moves it about 3.0%. For levels, the first level overhead is $45.00 (9.5% away) and the first support below is $40.00 (2.7% down). On the checklist the page runs for every asset, 5 of 6 checks read bullish — the lean is bullish.
TEVA is the more volatile of the two — an average session moves it 3.0% against 2.4% for LONN.SW, so an identical position size carries roughly 1.2× the daily risk.
The comparison turns on those levels: LONN.SW clearing $580.40 or losing $567.17; TEVA clearing $45.00 or losing $40.00. Until one of them gives way, the relative reading above stands.